Brief: Cabaletta Bio Reports Q1 2023 Financial Results And Provides Business Update
11/05/2023 13:46
May 11 (Reuters) - Cabaletta Bio Inc CABA.O :
* CABALETTA BIO REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
* EXPECTS THAT ITS CASH AND CASH EQUIVALENTS AS OF MARCH 31,
2023,
WILL ENABLE IT TO FUND ITS OPERATING PLAN INTO Q1 OF 2025
* QTRLY NET LOSS PER SHARE OF VOTING AND NON-VOTING COMMON
STOCK,
BASIC AND DILUTED $0.45
* Q1 EARNINGS PER SHARE VIEW $-0.48 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9YrQtC
Further company coverage: CABA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cabaletta Bio
See all newsCabaletta Bio Q1 net loss widens as R&D costs rise
Brief: First Patients Dosed With Cabaletta Bio’S Rese-Cel Manufactured On Cellares' Automated Cell Shuttle™ Platform
Brief: IND Amendment Clearance Obtained For Clinical Manufacturing Of Rese-Cel From Cabaletta Bio Using Cellares' Automated Platforms
Cabaletta Bio reports smaller-than-expected Q3 loss
U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, Doximity